timothy sykes logo
SXTP Stock Whipsaws As Traders Study Deep Red Financials Thumbnail
G Google News

SXTP Stock Whipsaws As Traders Study Deep Red Financials

ELLIS HOBBS•UPDATED OCT. 6, 2026, 9:19 AM ET
Reviewed by Jack Kelloggand Fact-checked by Tim Sykes

60 Degrees Pharmaceuticals Inc. faces heightened selling pressure as stocks have been trading down by -23.61 percent.

Key Takeaways

  • Shares of SXTP have bounced from below $1.00 to the mid‑$1.00s, signaling rising volatility that short‑term traders like to stalk.
  • The latest quarter shows 60 Degrees Pharmaceuticals Inc. generating about $0.2M in revenue against more than $2.4M in expenses, a steep cash burn profile.
  • SXTP’s current ratio near 2.3 and over $1.0M in cash give the company some near‑term breathing room despite heavy losses.
  • Intraday SXTP trading shows repeated spikes above $1.50 that sellers quickly fade, creating a clear battleground zone.

Candlestick Chart

Live Update At 09:18:43 EDT: On Tuesday, October 06, 2026 60 Degrees Pharmaceuticals Inc. stock [NASDAQ: SXTP] is trending down by -23.61%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

SXTP is a classic high‑risk, story‑driven small cap with numbers that scream caution. 60 Degrees Pharmaceuticals Inc. reported quarterly revenue of roughly $0.21M while total expenses climbed to about $2.48M. That translated into a net loss of around $2.26M and an EPS of about -$0.90 on just 2.65M diluted shares. For traders, that means dilution risk and financing questions stay front and center.

Profitability metrics are deeply negative. SXTP shows an EBIT margin near -674% and a profit margin that is also sharply in the red. Return on assets and return on equity are heavily negative as well, so the core business is far from breakeven.

More Breaking News

On the flip side, 60 Degrees Pharmaceuticals Inc. still has some runway. The balance sheet shows total assets near $4.28M, with cash around $1.02M and working capital above $2.1M. SXTP’s current liabilities are about $1.6M, and long‑term debt appears modest at roughly $0.15M. A current ratio near 2.3 tells traders the company can cover short‑term bills, but the cash burn of more than $2.2M per quarter means the clock is ticking.

Why Traders Are Watching SXTP Price Action

The chart is where SXTP gets interesting for active traders. On the daily timeframe, 60 Degrees Pharmaceuticals Inc. climbed from sub‑$1.00 levels to recent closes in the $1.30–$1.40 range. That’s a strong percentage move in a short window, exactly the kind of extension momentum traders hunt. The run from about $0.85–$0.95 up toward $1.44–$1.55 shows clear expansion in range and volatility.

Look at the intraday tape and SXTP trading becomes even more revealing. Pre‑market action shows repeated pushes into the $1.50–$1.75 zone, followed by sharp pullbacks into the low $1.40s and then the $1.30s. That tells traders there is a pocket of aggressive selling above $1.50, with dip buyers stepping in each time SXTP fades toward prior support levels.

For 60 Degrees Pharmaceuticals Inc., this kind of whipsaw price action often precedes a bigger move. SXTP is holding above the psychological $1.00 line, which matters for listing rules and trader psychology. Each higher low on the daily chart suggests short sellers are taking profits and fresh traders are stepping in on dips.

At the same time, the intraday five‑minute candles show lower highs after the first spike, hinting at a possible consolidation or a looming fade. In practice, that sets up SXTP as a prime watchlist name for both breakout traders looking for a clean push through $1.60–$1.70, and short‑biased traders waiting for a crack back below $1.30 if momentum dries up.

Conclusion

SXTP sits at the crossroads of ugly fundamentals and tradable volatility. 60 Degrees Pharmaceuticals Inc. is burning more than $2.2M in operating cash per quarter on less than $0.3M in revenue. Margins, returns, and earnings are all sharply negative. That is why long‑term fundamental bulls need to be extremely careful here. The company does have cash and working capital, but unless SXTP grows revenue meaningfully or cuts costs, more financing and potential dilution remain real possibilities.

From a trader’s lens, though, that same risk profile is exactly what can fuel big intraday moves. SXTP has already shown it can run from under $1.00 to the mid‑$1.00s in a blink. With such a small float and a history of aggressive selling into spikes, 60 Degrees Pharmaceuticals Inc. fits the classic “hot potato” pattern that active traders at timothysykes.com track daily.

The key is discipline. As Tim Sykes likes to remind traders, “Cut losses quickly, because small losses are the cost of admission to big wins.” As millionaire penny stock trader and teacher Tim Sykes says, “Cut losses quickly, let profits ride, and don’t overtrade.” Anyone trading SXTP needs that mindset. Respect the levels, map the range around $1.00 support and $1.50–$1.70 resistance, and let the chart of SXTP—not hope—dictate the trade. This is educational, research‑driven territory, not a place to confuse trading with long‑term safety.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”